Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 2107 record(s)

Req # A-2019-001876

All foreign inspection reports between 2010 and 2015 for the following six companies (ony the inspection reports, without all the attachments): Mylan, Apotex, Actavis, Pharmascience, Sandoz, Ranbaxy.

Organization: Health Canada

27 page(s)
January 2021

Req # A-2019-002047

All records (including Site Evaluations) utilized by Health Canada when assessing applications for Micro-processing license applications under the Cannabis Act that also include but not limited to providing training or guidance to reviewers of applications.

Organization: Health Canada

461 page(s)
January 2021

Req # A-2020-000276

Copies of all documents, excluding emails produced or held by Health Canada regarding Canada's preparedness for a pandemic, epidemic or breakout of an infectious disease between September 1, 2019 and March 13, 2020.

Organization: Health Canada

0 page(s)
January 2021

Req # A-2020-000396

Any Periodic Safety Update Report(s) (PSUR) for Truvada (produced by Gilead Sciences Canada Inc.) submitted to Health Canada between 2012 and 2018.

Organization: Health Canada

128 page(s)
January 2021

Req # A-2020-000401

All documents from general directions up regarding the risks of coronavirus contamination among seniors in long-term care centres and seniors' residences in Quebec and the rest of Canada. Final copies from Dec. 15, 2019 to June 22, 2020.

Organization: Health Canada

12 page(s)
January 2021

Req # A-2019-001367

Adverse Reaction Report (AER). Report number: E2B_02341462.

Organization: Health Canada

24 page(s)
January 2021

Req # A-2020-000629

Copies of any documents showing the allocation and distribution of personal protective equipment (PPE) acquired by the federal government, including breakdowns by province from March 15, 2020 to July 27, 2020.

Organization: Health Canada

166 page(s)
January 2021

Req # A-2020-001199

Competition posters for all positions at Health Canada's (HC) Access to Information and Privacy (ATIP) office in Ottawa between 1995 and 2005 and the dates the positions were staffed.

Organization: Health Canada

0 page(s)
January 2021

Req # A-2020-001229

Copies of all communications sent/rec'd by officials at the Director General (DG), Assistant Deputy Minister (ADM) or Deputy Minister (DM) level regarding or discussing private COVID-19 tests for Member's of Parliament (MPs) as from November 1, 2020 to November 25, 2020.

Organization: Health Canada

0 page(s)
January 2021

Req # A-2020-001248

Master Data/Core Data/Core Safety data from the Periodic Safety Update Reports (PSURs) submitted between the initial marketing authorization date and 1995 for Engerix-B and Recombivax HB. Include all reviews done by the U.S. Food and Drug Administration submitted by the MAH (Merck) to Health Canada for its pharmacovigilance review.

Organization: Health Canada

0 page(s)
January 2021
Date modified: